These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16730214

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Hypersexuality due to dopaminergic drugs.
    Prescrire Int; 2005 Dec; 14(80):224. PubMed ID: 16400746
    [Abstract] [Full Text] [Related]

  • 4. Effect of selegiline on cognitive functions in Parkinson's disease.
    Dixit SN, Behari M, Ahuja GK.
    J Assoc Physicians India; 1999 Aug; 47(8):784-6. PubMed ID: 10778622
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Compulsive singing: another aspect of punding in Parkinson's disease.
    Bonvin C, Horvath J, Christe B, Landis T, Burkhard PR.
    Ann Neurol; 2007 Nov; 62(5):525-8. PubMed ID: 17696122
    [Abstract] [Full Text] [Related]

  • 7. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy.
    Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE.
    Parkinsonism Relat Disord; 2005 Sep; 11(6):381-6. PubMed ID: 16109498
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Compulsive eating and weight gain related to dopamine agonist use.
    Nirenberg MJ, Waters C.
    Mov Disord; 2006 Apr; 21(4):524-9. PubMed ID: 16261618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impulsive and compulsive behaviors in Parkinson's disease: a one-year follow-up study.
    Ávila A, Cardona X, Martín-Baranera M, Bello J, Sastre F.
    J Neurol Sci; 2011 Nov 15; 310(1-2):197-201. PubMed ID: 21683375
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ, Swope DM, Dashtipour K.
    Clin Ther; 2007 Sep 15; 29(9):1825-49. PubMed ID: 18035186
    [Abstract] [Full Text] [Related]

  • 14. Dopamine agonist-triggered pathological behaviors: surveillance in the PD clinic reveals high frequencies.
    Hassan A, Bower JH, Kumar N, Matsumoto JY, Fealey RD, Josephs KA, Ahlskog JE.
    Parkinsonism Relat Disord; 2011 May 15; 17(4):260-4. PubMed ID: 21310646
    [Abstract] [Full Text] [Related]

  • 15. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease.
    Kimber TE, Thompson PD, Kiley MA.
    J Clin Neurosci; 2008 Feb 15; 15(2):205-8. PubMed ID: 18068992
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
    Voon V, Fernagut PO, Wickens J, Baunez C, Rodriguez M, Pavon N, Juncos JL, Obeso JA, Bezard E.
    Lancet Neurol; 2009 Dec 15; 8(12):1140-9. PubMed ID: 19909912
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Zoophilia and Parkinson's disease.
    Almeida KJ, de Oliveira Filho MC, Lopes Nery PC, Guimarães Silva JS, Campos Sousa RN.
    Parkinsonism Relat Disord; 2013 Dec 15; 19(12):1167-8. PubMed ID: 23973014
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.